Orbimed Advisors LLC Cybin Inc. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.26 - $0.64 $1.32 Million - $3.24 Million	-5,067,301 Reduced 48.47%	5,386,299 $1.62 Million
Q3 2022 Nov 14, 2022	SELL	$0.48 - $1.11 $33,936 - $78,477	-70,700 Reduced 0.67%	10,453,600 $5.08 Million
Q4 2021 Feb 14, 2022	SELL	$1.13 - $2.31 $3.3 Million - $6.75 Million	-2,922,821 Reduced 21.74%	10,524,300 $12.5 Million
Q3 2021 Nov 15, 2021	BUY	$1.83 - $3.18 $24.6 Million - $42.8 Million	13,447,121 New	13,447,121 $29.5 Million

102

270M

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $1.47B
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.